Human genome editing – the issues explored
Hayley Clissold from the Sanger Institute's policy team team explores the issues surrounding gene editing and human embryos
Careers | Find us | Contact us
2022-11-24T10:26:05+00:0020 December 2018|
Hayley Clissold from the Sanger Institute's policy team team explores the issues surrounding gene editing and human embryos
2017-08-03T16:05:37+01:003 August 2017|
03.08.17 This week the American Society of Human Genetics issued a policy on the application of germline editing – the ability to alter the genetic makeup of early stage embryos. Anna Middleton, one of the contributors to the statement, explains the policy's position
Wellcome Genome Campus,
Hinxton, Cambridgeshire,
CB10 1SA. UK
+44 (0)1223 834244
Wellcome Genome Campus,
Hinxton, Cambridgeshire, CB10 1SA. UK
+44 (0)1223 834244